Figures & data
Table 1. Model inputs.
Figure 2. Efficacy sources for zuranolone and SSRIs.
aITC reference: Meltzer-BrodyCitation62. b Observation time points correspond to months 8, 21, and 33, respectively, from Netsi et al.
Abbreviations: EPDS, Edinburgh Postnatal Depression Scale; LOCF, last observation carried forward; PPD, postpartum depression; SSRI, selective serotonin reuptake inhibitor; ZRN, zuranolone; ITC, indirect treatment comparison.
![Figure 2. Efficacy sources for zuranolone and SSRIs.aITC reference: Meltzer-BrodyCitation62. b Observation time points correspond to months 8, 21, and 33, respectively, from Netsi et al.Abbreviations: EPDS, Edinburgh Postnatal Depression Scale; LOCF, last observation carried forward; PPD, postpartum depression; SSRI, selective serotonin reuptake inhibitor; ZRN, zuranolone; ITC, indirect treatment comparison.](/cms/asset/49cebef1-42b1-41c9-9815-6ec73bfd3dec/ijme_a_2327946_f0002_b.jpg)
Table 2. Summary of base case results (11-year time horizon).
Table 3. Scenario analysis.
Figure 3. One-way sensitivity analysis.
Note: Change from baseline input values were negative, such that the high value represented the smaller numerical change.
Abbreviations: WTP, willingness-to-pay; QALY, quality-adjusted life year; BL, baseline; PPD, postpartum depression; SSRI, selective serotonin reuptake inhibitor.
![Figure 3. One-way sensitivity analysis.Note: Change from baseline input values were negative, such that the high value represented the smaller numerical change.Abbreviations: WTP, willingness-to-pay; QALY, quality-adjusted life year; BL, baseline; PPD, postpartum depression; SSRI, selective serotonin reuptake inhibitor.](/cms/asset/9487edf6-782f-49fd-a8a9-0fa338a718f6/ijme_a_2327946_f0003_c.jpg)